Is protracted low-dose temozolomide feasible in glioma patients?

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2005 • 18,835 citations

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

2000 • 940 citations

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

2001 • 373 citations

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

2003 • 365 citations

Phase I trial of temozolomide using an extended continuous oral schedule.

1998 • 284 citations

Selective CD4⁺ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

2004 • 259 citations

Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection

2000 • 248 citations

One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma

2004 • 157 citations

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

2002 • 104 citations

Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors

2003 • 35 citations